Dr. Jen Bachorik, Senior Counsel with The Marbury Law Group, has more than 14 years of experience in intellectual property law, including global strategic counseling and preparation and prosecution of patent applications in life sciences, pharmaceuticals, and biotechnology. Dr. Bachorik’s practice also encompasses due diligence, freedom-to-operate analyses, inventorship determination, pre-trial litigation, and inter partes review (IPR) proceedings. She has managed large international patent portfolios covering FDA-approved therapies, including marketed antibody-drug conjugates (ADCs) and enzyme replacement therapies, as well as pre-clinical and clinical stage assets across a broad range of therapeutic areas. She also has significant experience securing patent term extension (PTE) globally for marketed FDA-approved drugs.
Legal Career
Dr. Bachorik pursued her law degree at Temple University Beasley School of Law as an evening division student while working full-time as a patent agent. Upon graduating, she received the Robert C. Podwil Memorial Prize, awarded annually to the Temple Law graduate demonstrating excellent academic performance in intellectual property. She also earned distinctions for best papers in antitrust and legal research and writing. Prior to joining The Marbury Law Group, Dr. Bachorik practiced in the intellectual property group of an AmLaw 100 international law firm.
Dr. Bachorik has been recognized in Best Lawyers in America® “Ones to Watch” consecutively from 2021 through 2026. She is admitted to practice in New York, Pennsylvania, and Wisconsin, and before the U.S. Patent and Trademark Office (USPTO). She is a member of the New York Intellectual Property Law Association, the Intellectual Property Owners Association’s Pharmaceutical & Biotechnology Issues Committee, the PTAB Bar Association, and the State Bar of Wisconsin.
Technical Expertise & Scientific Background
Her experience spans a wide range of technologies: ADCs, enzyme replacement therapies, cell-based therapies (including CAR-T cells), immunotherapies, therapeutic antibodies, virology, vaccines, gene therapies, RNA biochemistry and therapeutics, neurodegenerative disease, transdermal drug delivery, and agricultural biotechnology.
Before her legal career, Dr. Bachorik earned her Ph.D. in Cellular and Molecular Biology from the University of Wisconsin-Madison, where her thesis work in the Howard Hughes Medical Institute laboratory of Dr. Judith Kimble focused on the role of RNA-binding proteins in germline development using genetics and molecular biology approaches. She then conducted post-doctoral research at the University of Pennsylvania in the HHMI laboratory of Dr. Gideon Dreyfuss on the biochemical basis of spinal muscular atrophy (SMA). During this time Jen was a coauthor on a review article that was awarded the FEBS Letters Most Cited Paper 2008 Award from Elsevier. That scientific foundation, which encompasses a unique combination of cell and molecular biology, biochemistry, and classical genetics, directly informs how she counsels clients on the strength and scope of their IP.
Work & Education History
Education
- Temple University Beasley School of Law (J.D.)
- University of Wisconsin-Madison (Ph.D., Cellular and Molecular Biology, Department of Biochemistry)
- University of Pennsylvania (B.A., Music, magna cum laude)
Admissions
- New York
- Pennsylvania
- Wisconsin
- U.S. Patent and Trademark Office (USPTO)
Memberships
- New York Intellectual Property Law Association (NYIPLA)
- Intellectual Property Owners Association (IPO), Pharmaceutical &
- Biotechnology Issues Committee
- PTAB Bar Association
- State Bar of Wisconsin
